Medical Science Liaison/Senior Medical Science Liaison, Alzheimer's Disease Agitation (Plains Region)

Company Description

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X .

About This Role

Axsome Therapeutics is seeking a Medical Science Liaison/Senior Medical Science Liaison to focus on developing the ADA franchise. The MSL/Senior MSL will be a key member of the Field Medical Affairs team at Axsome. This position will be the primary communicator of Axsome science and will be responsible for executing the national medical affairs plan within a specified territory. The MSL/Senior MSL will also provide support as needed for other pipeline programs.

This is a field-based position covering the Plains Region (IL, MO, NE, KS, IA) . Candidates must reside within the geography.

Job Responsibilities and Duties include, but are not limited to, the following:

• Systematically identify and develop relationships with healthcare professionals (HCPs) to raise awareness of Axsome’s mission to accelerate the invention and adoption of life-changing medicines for patients living with CNS disorders

• Develop and maintain a deep knowledge and understanding of neuropsychiatry and approved pipeline medications as well as the competitive landscape in the specified therapeutic area

<li data-leveltext="" data-font="Symbol" data-listid="10" data-list-defn-props="{"335552541":1,"335559685":360,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":&